Success Stories: Egyptian Graduate Researcher Wins NIW Approval for Innovative Research on Diabetes Therapies

Client’s Testimonial:

“Thank you so much for helping me to get approval for my EB2/NIW. I am willing to continue my journey till getting the green card with such a wonderful and professional attorney.”

On September 18^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Researcher in the field of Biomedical Sciences (Approval Notice).

General Field: Biomedical Sciences

Position at the Time of Case Filing: Graduate Researcher

Country of Origin: Egypt

Country of Residence at the Time of Filing: United Arab Emirates

Approval Notice Date: September 18^th, 2025

Processing Time: 1 year, 8 months, 2 days

Case Summary:

We are pleased to announce the EB-2 NIW (National Interest Waiver) approval of a graduate researcher from Egypt. At the time of filing, she was conducting research abroad, focusing on therapeutic targets for diabetes and cardiometabolic diseases. Her strong publication record, citation impact, and service as a peer reviewer established her as a compelling candidate for NIW approval.

Driving National Impact in Healthcare

The client is best known for her studies on oxidative stress, inflammation, and mitochondrial dysfunction. Her research shows how cannabinoids, terpenes, and natural compounds can reduce organ injury and improve treatment outcomes, including in cases of chemotherapy-induced damage. These contributions are particularly significant given that diabetes and its complications remain among the most widespread and costly health challenges in the United States.

By advancing strategies that could ease the burden of chronic disease and reduce long-term healthcare costs, her work supports U.S. priorities in public health and biomedical innovation.

Scholarly Credentials and Recognition

The client holds a Ph.D. in biomedical science and has authored 9 peer-reviewed journal articles, 6 of them as first author, as well as 2 abstracts, a first-authored book chapter, and a first-authored book. Her studies, published in respected journals such as Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, and Nutrients, have been cited 192 times by independent researchers. Notably, six of her articles rank among the top 10 percent of most cited papers in clinical medicine for their publication years.

In addition, she has completed at least 2 reviews for journals, including Complementary Medicine and Pharmacology and the International Journal of Molecular Sciences. These contributions reflect her recognition as a trusted evaluator of research and her standing in the biomedical sciences community.

Expert Endorsements

Letters from independent experts confirmed her reputation for originality and impact. One recommender wrote:

“Through the results of [client]’s studies in biomedical sciences, countless individuals affected by diabetes are given better treatment methods, minimizing the fatalities caused by diabetes and diabetic cardiomyopathy.”

Such testimonials reinforced her profile as a researcher whose findings are not only scientifically innovative but also vital to public health.

NIW Approval and Outlook

The I-140 NIW petition was filed on January 16, 2024, and approved on September 18, 2025. USCIS recognized her scholarly output, citation influence, service as a reviewer, and the national importance of her proposed endeavor as sufficient to satisfy the NIW requirements.

With NAILG’s support, the client secured NIW approval and is now prepared to continue her research in the United States. Her ongoing studies are expected to contribute to the development of new therapies for diabetes and related conditions, strengthening U.S. leadership in biomedical science and chronic disease treatment.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.